Opportunities for Canada to Improve Global Access to Medicines

Wojciech Copija, Lauren Degabriele, M Hosseini, Ashley Schram, Liliane Tshiama Kalonji

    Research output: Book/ReportCommissioned reportpeer-review


    This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally. Four market-level case studies focus on innovative financing and collaborative initiatives as ways to enhance Canadas global standing on pharmaceutical R&D. One patient-level case study considers international legislation as a model to improve Canadas purchasing power.
    Original languageEnglish
    Place of PublicationOttawa, Canada
    Commissioning bodyGlobal Strategy Lab
    Publication statusPublished - 2016


    Dive into the research topics of 'Opportunities for Canada to Improve Global Access to Medicines'. Together they form a unique fingerprint.

    Cite this